英文品名 |
中文品名 |
CAS NO. |
描述 |
规格 |
2’Fucosyllactose / 2-FL |
2’-岩藻糖基乳糖 |
41263-94-9 |
Fucα1-2Galβ1-4Glc |
5mg |
2’Fucosyllactose / 2-FL |
2’-岩藻糖基乳糖 |
41263-94-9 |
Fucα1-2Galβ1-4Glc |
25mg |
3 Fucosyllactose / 3-FL |
3-岩藻糖基乳糖 |
41312-47-4 |
Galβ1-4(Fucα1-3)Glc |
5mg |
3 Fucosyllactose / 3-FL |
3-岩藻糖基乳糖 |
41312-47-4 |
Galβ1-4(Fucα1-3)Glc |
25mg |
Isglobotetraose / iGb4 / Cytolipin R |
细胞糖脂R |
|
GalNAcβ1-3Galα1-3Galβ1-4Glc |
5mg |
Lacto-N-tetraose / LNT |
乳糖-N-四糖 |
14116-68-8 |
Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
5mg |
Lacto-N-tetraose / LNT |
乳糖-N-四糖 |
14116-68-8 |
Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
25mg |
Lacto-N-neotetraose / LNnT / neo-LNT |
乳糖-N-新四糖 |
13007-32-4 |
Galβ1-4GlcNAcβ1-3Galβ1-4Glc |
5mg |
Lacto-N-neotetraose / LNnT / neo-LNT |
乳糖-N-新四糖 |
13007-32-4 |
Galβ1-4GlcNAcβ1-3Galβ1-4Glc |
25mg |
Lacto-N-fucopentaose I / LNFP I |
乳糖-N-岩藻戊糖 I |
7578-25-8 |
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
5mg |
Lacto-N-fucopentaose I / LNFP I |
乳糖-N-岩藻戊糖I |
7578-25-8 |
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
25mg |
Lacto-N-difucohexaose II / LNDFH II |
乳糖-N-二岩藻己糖II |
62258-12-2 |
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
5mg |
Lacto-N-difucohexaose II / LNDFH II |
乳糖-N-二岩藻己糖II |
62258-12-2 |
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
25mg |
Para-Lacto-N-neohexaose / Para-LNnH |
Para-乳糖-N-新己糖 |
64331-48-2 |
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc C40H68N2O31 |
5mg |
Para-Lacto-N-neohexaose / Para-LNnH |
Para-乳糖-N-新己糖 |
64331-48-2 |
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc C40H68N2O31 |
25mg |
Lacto-N-neooctaose / LNnO |
乳糖-N-新八糖 |
|
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3 |
5mg |
Lacto-N-neooctaose / LNnO |
|
|
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3 |
25mg |
Lacto-N-fucopentaose V / LNFP V |
乳糖-N-岩藻戊糖V |
60254-64-0 |
Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
5mg |
Lacto-N-fucopentaose V / LNFP V |
乳糖-N-岩藻戊糖V |
60254-64-0 |
Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
25mg |
Lacto-N-neofucopentaose / LNnFP-V / LNFP VI |
乳糖-N-新岩藻戊糖 VI |
|
Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
5mg |
Lacto-N-neofucopentaose / LNnFP-V / LNFP VI |
乳糖-N-新岩藻戊糖 VI |
|
Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc |
25mg |
3’Sialyl-3Fucosyllactose / F-SL |
3’唾液酸化-3岩藻糖基乳糖 |
|
Neucα2-3Galβ1-4(Fucα1-3)Glc |
5mg |
3’Sialyl-3Fucosyllactose / F-SL |
3’唾液酸化-3岩藻糖基乳糖 |
|
Neucα2-3Galβ1-4(Fucα1-3)Glc |
25mg |
LS-Tetrasaccharide a / LSTa / Sialyl-lacto-N-tetraose a |
LS-四糖 a |
64003-53-8 |
Neucα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
5mg |
LS-Tetrasaccharide a / LSTa / Sialyl-lacto-N-tetraose a |
LS-四糖 a |
64003-53-8 |
Neucα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
25mg |
GM3 Ganglioside sugar / 3'Sialyllactose / 3'SL / N-Acetylneuraminoyllactose |
神经节苷脂GM3 |
|
Neucα2-3Galβ1-4Glc |
100mg |
Blood group A antigen tetraose type 5 / PI |
血型A抗原类型5四糖 |
59957-92-5 |
GalNAcα1-3(Fucα1-2)Galβ1-4Glc |
5mg |
Blood group A antigen tetraose type 5 / PI |
血型A抗原类型5四糖 |
59957-92-5 |
GalNAcα1-3(Fucα1-2)Galβ1-4Glc |
25mg |
Blood group A antigen tetraose type 5 / PI |
血型A抗原类型5四糖 |
59957-92-5 |
GalNAcα1-3(Fucα1-2)Galβ1-4Glc |
100mg |
Blood group A antigen hexaose type 1 / PII |
血型A抗原类型1四糖 |
|
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3 |
5mg |
Blood group A antigen hexaose type 1 / PII |
血型A抗原类型1四糖 |
|
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3 |
25mg |
上海惠诚生物提供性价比高的母乳低聚糖HMOs,为您的科学研究提供强有力的支持!
联系电话:18018625233(同微信) QQ:2303607288
产品信息:其他哺乳类动物母乳低聚糖:
英文品名 |
中文品名 |
CAS No. |
描述 |
|
Lacto-N-tetraose / LNT |
乳糖-N-四糖 |
14116-68-8 |
Galβ1-3GlcNAcβ1-3Galβ1-4Glc |
25mg |
Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2-FL |
2’-岩藻糖基乳糖 |
41263-94-9 |
Fucα1-2Galβ1-4Glc |
5mg |
Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2-FL |
2’-岩藻糖基乳糖 |
41263-94-9 |
Fucα1-2Galβ1-4Glc |
25mg |
3 Fucosyllactose / 3-FL |
3-岩藻糖基乳糖 |
41312-47-4 |
Galβ1-4(Fucα1-3)Glc |
5mg |
3 Fucosyllactose / 3-FL |
3-岩藻糖基乳糖 |
41312-47-4 |
Galβ1-4(Fucα1-3)Glc |
25mg |
GM3 Ganglioside sugar / 3'Sialyllactose / 3'SL / N-Acetylneuraminoyllactose |
神经节苷脂GM3 |
35890-38-1 |
Neucα2-3Galβ1-4Glc |
100mg |
Lacto-N-neotetraose / LNnT / neo-LNT |
乳糖-N-新四糖 |
13007-32-4 |
Galβ1-4GlcNAcβ1-3Galβ1-4Glc |
5mg |
Lacto-N-neotetraose / LNnT / neo-LNT |
乳糖-N-新四糖 |
13007-32-4 |
Galβ1-4GlcNAcβ1-3Galβ1-4Glc |
25mg |
Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide |
3'-半乳糖基-乳糖 |
56038-36-9 |
Galα1-3Galβ1-4Glc |
5mg |
Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide |
3'-半乳糖基-乳糖 |
56038-36-9 |
Galα1-3Galβ1-4Glc |
25mg |
Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide |
3'-半乳糖基-乳糖 |
56038-36-9 |
Galα1-3Galβ1-4Glc |
100mg |
LewisX (LeX) triaose / SSEA-1 / CD15 |
LewisX三糖 |
71208-06-5 |
Galβ1-4(Fucα1-3)GlcNAc |
5mg |
References
1. C Kunz et al. Oligosaccharides in Human Milk: Structural, Functional, and metabolic Aspects. 2000. Ann. Rev. Nutr.20, 699-722.
2. G Boehm and B Stahl. Oligosaccharides. 2003. In Functional dairy products. p203-243. T Mattila-Sandholm and M Saarela, Editors. Boca Raton: CRC Press.
3. S Perret et al. Structural basis for the interaction between human milk oligosaccharide and the bacterial lectin PA-IIL of Pseudomonas aeruginosa”. 2005. Biochem J. Jul 15;389,325-332.
4. G Boehm and B Stahl. Oligosaccharides from Milk. 2007. J. Nutr. 137, 847S-849S.
5. A Kobata. Structures and application of oligosaccharides in human milk. 2010. Proc. Jpn. Acad. 86,731-749.
6. S Mills et al. Milk intelligence: Mining milk for bioactive substances associated with human health. 2011.International dairy journal. 21, 377-401.